United States Environmental Protection Agency
Integrated Risk Information System Logo


Thiophanate-methyl
CASRN 23564-05-8

Contents


0117
Thiophanate-methyl; CASRN 23564-05-8  


Health assessment information on a chemical substance is included in IRIS only 
after a comprehensive review of chronic toxicity data by U.S. EPA health 
scientists from several Program Offices and the Office of Research and 
Development.  The summaries presented in Sections I and II represent a 
consensus reached in the review process.  Background information and 
explanations of the methods used to derive the values given in IRIS are 
provided in the Background Documents. 


STATUS OF DATA FOR  Thiophanate-methyl

File On-Line 01/31/1987

Category (section)                           Status      Last Revised
-----------------------------------------    --------    ------------

Oral RfD Assessment (I.A.)                   on-line       01/01/1992

Inhalation RfC Assessment (I.B.)             no data     

Carcinogenicity Assessment (II.)             no data     



_I. CHRONIC HEALTH HAZARD ASSESSMENTS FOR NONCARCINOGENIC EFFECTS __I.A. REFERENCE DOSE FOR CHRONIC ORAL EXPOSURE (RfD) Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 Last Revised -- 01/01/1992 The oral Reference Dose (RfD) is based on the assumption that thresholds exist for certain toxic effects such as cellular necrosis. It is expressed in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. Please refer to the Background Document for an elaboration of these concepts. RfDs can also be derived for the noncarcinogenic health effects of substances that are also carcinogens. Therefore, it is essential to refer to other sources of information concerning the carcinogenicity of this substance. If the U.S. EPA has evaluated this substance for potential human carcinogenicity, a summary of that evaluation will be contained in Section II of this file. ___I.A.1. ORAL RfD SUMMARY Critical Effect Experimental Doses* UF MF RfD -------------------- ----------------------- ----- --- --------- Decreased body NOEL: 160 ppm 100 1 8E-2 weight, decreased (8 mg/kg/day) mg/kg/day spermatogenesis, and histological evidence LEL: 640 ppm of hyperthyrodism (32 mg/kg/day) 2-Year Rat Feeding Study Pennwalt Corp., 1972a
*Dose Conversion Factors & Assumptions: 1 ppm = 0.05 mg/kg/day (rat food consumption) ___I.A.2. PRINCIPAL AND SUPPORTING STUDIES (ORAL RfD) Pennwalt Corporation. 1972a. MRID No. 00032673, 00117868; HED Doc. No. 00200, 00203, 004260. Available from EPA. Write to FOI, EPA, Washington D.C. 20460. Four groups consisting of 35 male and 35 female SPF. Sprague-Dawley rats were given diets containing 10, 40, 160, or 640 ppm of thiophanate-methyl. A control group of 50 males and 50 females was included. The animals were checked daily for toxic signs and mortality. Body weight and food consumption were recorded. Hematologic and clinical chemistry testing, and blood analysis were performed periodically. At sacrifice, organ weight and histopathologic changes were also reported. The systemic NOEL was 160 ppm (8 mg/kg/day), and the LEL was 640 ppm (32 mg/kg/day). The treatment caused growth retardation, decreased spermatogenesis, and histologic evidence of hyperthyroidism. ___I.A.3. UNCERTAINTY AND MODIFYING FACTORS (ORAL RfD) UF -- A 100-fold uncertainty factor has been used to compensate for the inter- and intraspecies differences in extrapolating from rats to humans. MF -- None ___I.A.4. ADDITIONAL COMMENTS (ORAL RfD) Another reproduction study available was concerned only with effects on the male reproductive system. No effects were found at 195 mg/kg thiophanate- methyl, although there was an observed increase in adrenal weights (core grade minimum). Data Considered for Establishing the RfD 1) 2-Year Feeding (Oncogenic) - rat: Principal study - see discussion above; core grade minimum 2) 2-Year Feeding - dog: NOEL=50 mg/kg/day; LEL=250 mg/kg/day (growth retardation, elevated thyroid weight); core grade minimum (Pennwalt Corp., 1972b) 3) Teratology - rat: Teratogenic NOEL=2500 ppm (125 mg/kg/day) (HDT); Maternal NOEL=250 ppm (12.5 mg/kg/day), LEL=1200 ppm (60 mg/kg/day); Fetotoxic NOEL=2500 ppm (HDT); core grade minimum (Atochem North America, Inc., 1985) 4) Teratology - mice: The 1000 mg/kg/day dose caused decreased number of implantations; core grade supplementary (Incomplete descriptions of protocol, fetal examinations did not appear to include soft tissue examinations) (Pennwalt Corp., 1970a) 5) 3-Generation Reproduction - rat: Reproductive NOEL=160 ppm (8 mg/kg/day); LEL=640 ppm (32 mg/kg/day) (HDT) (reduced litter weights); core grade minimum (Pennwalt Corp., 1970c) Other Data Reviewed 1) 2-Year Feeding (Oncogenic) - Mice: Systemic NOEL=160 ppm (22.85 mg/kg/day); core grade minimum (Pennwalt Corp., 1970b) Data Gap(s): Rabbit Teratology Study ___I.A.5. CONFIDENCE IN THE ORAL RfD Study -- High Data Base -- High RfD -- High The principal study appears to be of high quality and is given a high rating. The data base is very supportive, but has one data gap; therefore, confidence in the data base can be considered high to medium. Confidence in the RfD can also be considered high to medium. ___I.A.6. EPA DOCUMENTATION AND REVIEW OF THE ORAL RfD Pesticide Registration Files Agency Work Group Review -- 03/11/1986 Verification Date -- 03/11/1986 ___I.A.7. EPA CONTACTS (ORAL RfD) Please contact the Risk Information Hotline for all questions concerning this assessment or IRIS, in general, at (513)569-7254 (phone), (513)569-7159 (FAX) or RIH.IRIS@EPAMAIL.EPA.GOV (internet address).
__I.B. REFERENCE CONCENTRATION FOR CHRONIC INHALATION EXPOSURE (RfC) Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 Not available at this time.
_II. CARCINOGENICITY ASSESSMENT FOR LIFETIME EXPOSURE Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 This substance/agent has not undergone a complete evaluation and determination under US EPA's IRIS program for evidence of human carcinogenic potential.
_VI. BIBLIOGRAPHY Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 Last Revised -- 01/01/1992 __VI.A. ORAL RfD REFERENCES Atochem North America, Inc. 1985. MRID No. 00146643, 92186011; HED Doc. No. 004459. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Pennwalt Corporation. 1970a. MRID No. 0055937; HED Doc. No. 00200, 004260. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Pennwalt Corporation. 1970b. MRID No. 00081611; HED Doc. No. 00200, 00203, 00206, 004260. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Pennwalt Corporation. 1972a. MRID No. 00032673, 00117868; HED Doc. No. 00200, 00203, 004260. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Pennwalt Corporation. 1972b. MRID No. 00055930, 00057652, 00080282, 00117869; HED Doc. No. 00200, 00203, 004260. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Pennwalt Corporation. 1972c. MRID No. 00055931, 00117870, 00057653; HED Doc. No. 00203, 004260. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
__VI.B. INHALATION RfC REFERENCES None
__VI.C. CARCINOGENICITY ASSESSMENT REFERENCES None
_VII. REVISION HISTORY Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 -------- -------- -------------------------------------------------------- Date Section Description -------- -------- -------------------------------------------------------- 03/31/1987 IV. Regulatory Action section on-line 03/01/1988 I.A.1. Dose conversion clarified 03/01/1988 I.A.4. Core grades added 03/01/1988 I.A.5. Confidence levels revised 03/01/1988 I.A.6. Documentation revised 01/01/1992 I.A.4. Citations added 01/01/1992 VI. Bibliography on-line 01/01/1992 IV. Regulatory actions updated
VIII. SYNONYMS Substance Name -- Thiophanate-methyl CASRN -- 23564-05-8 Last Revised -- 01/31/1987 23564-05-8 ALLOPHANIC ACID, 4,4'-o-PHENYLENEBIS(3-THIO-, DIMETHYL ESTER BAS 32500F 1,2-BIS(METHOXYCARBONYLTHIOUREIDO)BENZENE 1,2-BIS(3-(METHOXYCARBONYL)-2-THIOUREIDO)BENZENE o-BIS(3-METHOXYCARBONYL-2-THIOUREIDO)BENZENE CARBAMIC ACID, (1,2-PHENYLENEBIS(IMINOCARBONOTHIOYL))BIS-, DIMETHYL ESTER CERCOBIN M CERCOBIN METHYL DIMETHYL ((1,2-PHENYLENE)BIS-(IMINOCARBONOTHIOYL))BIS(CARBAMATE) DIMETHYL-4,4'-o-PHENYLENE-BIS-(3-THIOALLOPHANATE) ENOVIT M ENOVIT METHYL ENOVIT-SUPPER FRUMIDOR FUNGITOX FUNGO FUNGO 50 LABILITE METHYLTHIOFANATE METHYL THIOPHANATE METHYL TOPSIN MILDOTHANE NEOTOPSIN NF 44 PELT 14 PELT-44 SIGMA SIPCAPLANT SIPCASAN SIPCAVIT TD 1771 THIOPHANATE M Thiophanate-methyl TIOFANATE METILE TOPSIN M TOPSIN NF-44 TOPSIN WP METHYL TREVIN ZYBAN



IRIS Home Page Substance File List
Comments on the IRIS web site Search the IRIS database National Center for Environmental Assessment Office of Research and Development's Home Page EPA's Home Page


Last updated: 5 May 1998
URL: http://www.epa.gov/iris/SUBST/0117.HTM